Carregant...
Sulforaphane attenuates EGFR signaling in NSCLC cells
BACKGROUND: EGFR, a receptor tyrosine kinase (RTK), is frequently overexpressed and mutated in non-small cell lung cancer (NSCLC). Tyrosine kinase inhibitors (TKIs) have been widely used in the treatment of many cancers, including NSCLC. However, intrinsic and acquired resistance to TKI remains a co...
Guardat en:
| Publicat a: | J Biomed Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451877/ https://ncbi.nlm.nih.gov/pubmed/26036303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-015-0139-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|